JD

Jeani Delagardelle

Public & Private Board Director/Independent-Healthcare Technology at Independent Consultant

Burlingame, California

Invests in

Stages:

  • Min Investment:

    $0.00
  • Max Investment:

    $0.00
  • Target Investment:

    $0.00

Skills

Venture Capital
Mergers & Acquisitions
IPO
Medical Devices
Technology Transfer
Corporate Development
Equity Research
Biotechnology
Start-ups
Product Development
Investments
Strategic Planning
Commercialization
Oncology
Growth Capital
Private Companies
Financial Modeling
Venture Financing
Private Equity
Valuation

Education

Work Experience

Independent Consultant

2018

  • Public & Private Board Director/Independent-Healthcare Technology

    2018

    Over the past 21 years I have served as a Director on 24 Boards including both public and private companies, spanning multiple therapeutic areas and stages of companies from start ups to commercial stage. I have been on multiple Compensation Committees, Audit Committees, Financing Committees, Recruiting Committees and Chaired both Compensation and Audit Committees. I enjoy working closely with management teams and being an active Board Director.

Delos Capital/Independent

2018 - 2018

  • Venture Partner/Board Director

    2018 - 2018

    Experienced venture investor and business leader who specializes in founding, building, growth expansion of healthcare technology companies across all stages of development and therapeutic areas for either acquisition or IPO.

  • Managing Director/CoFounder

    2005 - 2018

    Led our Medical Device investing practice.

Worldheart (WHRT)

2008 - 2012

  • Public Company Board Director;Chair of the Compensation Committee

    2008 - 2012

    The Company developed an implantable ventricular assist device for adults, children and infants suffering from heart failure in the United States. The VAD's are mechanical assist devices that supplement the circulatory function of the heart by re-routing blood flow through a mechanical pump allowing for the restoration of normal blood flow. The Company was sold to Heartware, Inc. in 2012.

2000 - 2005

  • General Partner

    2000 - 2005

    Led the medical device investment practice.

Weiss Peck & Greer Ventures

1997 - 2000

  • General Partner

    1997 - 2000

    Led the medical device investment practice.

Target Therapeutics/Boston Scientific

1996 - 1997

  • Vice President Global Marketing

    1996 - 1997

Roche Pharmaceuticals

1995 - 1996

  • Business Unit Director

    1995 - 1996

    P & L Leadership for a Business Unit generating $63 million in sales. Special Achievement Award recipient in 1995.

CellPro, Inc

1994 - 1995

  • Director of Product Marketing

    1994 - 1995

1986 - 1994

  • Group Product Marketing Manager

    1986 - 1994

    previous positions while at BSC include sales representative, Regional Manager.